Does the Level of Reproductive Knowledge Specific to Inflammatory Bowel Disease Predict Childlessness among Women with Inflammatory Bowel Disease? by Vivian W Huang, Hsiu-Ju Chang, Karen I Kroeker, Karen J Goodman, Kathleen M Hegadoren, Levinus A Dieleman, Richard N Fedorak

“…BACKGROUND: Women with inflammatory bowel disease (IBD) may choose to remain childless due to a lack of IBD-specific reproductive knowledge.…”
Get full text

The Approach to Dysplasia Surveillance in Inflammatory Bowel Disease by Remo Panaccione

Get full text

Pitfalls in the Radiological Diagnosis of Inflammatory Bowel Disease by GP LeBrun

“…Effective management of patients with inflammatory bowel disease (IBD) depends upon accurate diagnosis. …”
Get full text

Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update by Shane O’Sullivan, John F. Gilmer, Carlos Medina

“…Matrix metalloproteinases (MMPs) are known to be upregulated in inflammatory bowel disease (IBD) and other inflammatory conditions, but while their involvement is clear, their role in many settings has yet to be determined. …”
Get full text

Leukocyte migration in experimental inflammatory bowel disease by E. P. Van Rees, M. J. H. J. Palmen, F. R. W. Van De Goot, B. A. Macher, L. A. Dieleman

“…The influx of neutrophils, monocytes and lymphocytes into inflamed tissue is important in the pathogenesis of chronic inflammatory bowel disease. The importance of each of these groups of adhesion molecules in chronic inflammatory bowel disease, either in human disease or in animal models, will be discussed below. …”
Get full text

The current standard of care of inflammatory bowel disease by J Wright

Get full text

Self-Management for People with Inflammatory Bowel Disease by Fred Saibil, Emily Lai, Andrew Hayward, Jeanne Yip, Cameron Gilbert

“…The present paper reviews some of the literature on self-management for the patient with inflammatory bowel disease (IBD), and provides a framework for the use of self-management in the IBD population, with emphasis on the concept of a patient passport, and the use of e-mail, supported by an e-mail contract, as proposed by the Canadian Medical Protective Association. …”
Get full text

Noninvasive markers of inflammatory bowel disease activity by A. V. Nikitin, L. V. Vasilyeva, Anatoly A. Matiukhin

“…To study noninvasive activity markers of inflammatory bowel diseases (IBD) and to estimate correlation between various diagnostic methods for an assessment of clinical and endoscopical activity of ulcerative colitis (UC) and Crohn's disease (CD). …”
Get full text

The Role of Macrophages in the Pathogenesis of Inflammatory Bowel Disease by YR Mahida

Get full text

Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases by Donatella Comito, Claudio Romano

“…Inflammatory bowel diseases (IBDs) are chronic inflammatory conditions of the gastrointestinal tract that occur in genetically susceptible individuals. …”
Get full text

Immunization History of Children with Inflammatory Bowel Disease by Ing Shian Soon, Jennifer CC deBruy, Iwona Wrobel

“…BACKGROUND: Protection against vaccine-preventable diseases is important in children with inflammatory bowel disease (IBD) due to frequent immunosuppressive therapy use. …”
Get full text

Management of Musculoskeletal Manifestations in Inflammatory Bowel Disease by Tejas Sheth, C. S. Pitchumoni, Kiron M. Das

“…Biological therapies have revolutionized management of inflammatory bowel diseases as well as of associated articular manifestations. …”
Get full text

Update of Immunomodulatory Therapy for Inflammatory Bowel Disease by Charles N Bernstein

“…For several decades corticosteroids were the only potent immunomodulatory agents effective and available for active inflammatory bowel disease (IBD). The past decade ha seen an enhanced knowledge of the immune response in lBD and a better understanding of how common immunomodulatory agents work. …”
Get full text

Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease by Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, Rafał Filip

“…NAFLD is an increasingly described disease in patients with inflammatory bowel disease (IBD). Recent data also indicate a frequent coexistence of metabolic syndrome in this group of patients. …”
Get full text

Immune-Mediated Cytotoxicity in Inflammatory Bowel Disease by Stephan R Targan, Richard L Deem, Fergus Shanahan

“…Thirty years of research on the role of immune-mediated cytotoxic activity in the tissue injury of inflammatory bowel disease (IBD) has yielded only inconclusive data on the relevance of cytotoxic mechanisms. …”
Get full text

Sense of Coherence in Patients with Inflammatory Bowel Disease by Randi Opheim, May Solveig Fagermoen, Lars-Petter Jelsness-Jørgensen, Tomm Bernklev, Bjørn Moum

“…The aim of this study was to explore associations between SOC and sociodemographic, disease-related, and personal characteristics in a sample of patients with inflammatory bowel disease (IBD). Methods. Measures included sociodemographic and disease-related data, the Sense of Coherence Scale, General Self-Efficacy Scale (GSE), and Fatigue Severity Scale (FSS-5). …”
Get full text

Immunosuppressive and Immunomodulatory Therapy for Inflammatory Bowel Disease by Charles N Bernstein, Fergus Shanahan

Get full text

Clinical Quality Indicators in Inflammatory Bowel Disease by Subrata Ghosh

Get full text

World Perspectives: The OMGE Database for Inflammatory Bowel Disease by De Dombal F Timothy

Get full text

Overview of Newer Glucocorticosteroid Preparations for Inflammatory Bowel Disease by R Brattsand

“…However, based on a new generation of glucocorticosteroids characterized by a high first pass metabolism in the liver, it seems possible today co reach a more selective topical therapy of inflammatory bowel disease. The properties of three new glucocorticosteroids are presented: the highly potent budesonide, fluticasone propionate and tixocortol pivalate - the latter with only low topical potency. …”
Get full text